Wolverine Asset Management »

Cytokinetics shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $170M 96M 1.76
2023-09-30 $76M 89M 0.85

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Cytokinetics

Wolverine Asset Management
Weiss Asset Management LP[1
D. E. Shaw & Co
Balyasny Asset Management
Millennium Management
DeepCurrents Investment Group
Graham Capital Management
Point72 Asset Management
Readystate Asset Management
Polygon Management
CNH Partners
Jane Street
Partner Fund Management
Polar Securities
Lord, Abbett & Co

View all funds holding Cytokinetics